Arrowstreet Capital
AMAG

Arrowstreet Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Arrowstreet Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-194,207
Closed -$4.38M – 1419
2017
Q1 		$4.38M Buy
+194,207
New +$4.65M 0.02% 602
2015
Q3 		– Sell
-103,200
Closed -$7.13M – 1553
2015
Q2 		$7.13M Buy
+103,200
New +$6.49M 0.04% 342
2014
Q2 		– Sell
-54,976
Closed -$1.06M – 1253
2014
Q1 		$1.06M Buy
54,976
+41,738
+315% +$887K 0.01% 814
2013
Q4 		$321K Buy
+13,238
New +$311K ﹤0.01% 1046

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital's AMAG Position: Q2 2017 in Review

Arrowstreet Capital sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 194,207 shares — an estimated $4.38M sold.

Arrowstreet Capital first reported a position in AMAG in Q4 2013 and held it in 4 quarters. The position peaked at $7.13M in Q2 2015. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Arrowstreet Capital reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Arrowstreet Capital sold 194,207 AMAG Pharmaceuticals shares in Q2 2017, an estimated $4.38M.
  • Arrowstreet Capital first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Arrowstreet Capital's AMAG Pharmaceuticals position peaked at $7.13M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Arrowstreet Capital's 13F filing for Q2 2017, filed 15 Aug 2017.